Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Seitz

Showing results (191-200 of 219) with videos related to

Pageof 22
Sort By:
The Journal of Biological Chemistry|September 5, 2001
RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancerB S Finlin, C L Gau, G A Murphy, et al.
Plos One|May 1, 2020
Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational researchJose Rodrigo Espinosa Fernandez, Bedrich L Eckhardt, Jangsoon Lee, et al.
Clinical Radiology|April 12, 2017
Strengths and limitations of coronary angiography with turbo high-pitch third-generation dual-source CTM M Ochs, F Andre, G Korosoglou, et al.
JCO Precision Oncology|February 17, 2022
Clinical Activity of Pembrolizumab in a Patient With Metastatic Triple-Negative Breast Cancer Without Tumor Programmed Death-Ligand 1 Expression: A Case Report and Correlative Biomarker AnalysisSajjad Bhatti, Jaimie Heldstab, Carolyn Lehn, et al.
Clinical Lung Cancer|December 23, 2022
27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer StudyDavid L Saltman, Matthew G Varga, Tyler J Nielsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancerBrian Z Ring, Robert S Seitz, Rod Beck, et al.
Breast Cancer Research : BCR|July 10, 2010
Mammostrat as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapyJohn M S Bartlett, Jeremy Thomas, Douglas T Ross, et al.
Astrobiology|December 6, 2023
The Atacama Rover Astrobiology Drilling Studies (ARADS) ProjectB Glass, D Bergman, V Parro, et al.
Human Reproduction (Oxford, England)|July 6, 2016
Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery ratesH Van der Ven, J Liebenthron, M Beckmann, et al.
BMC Cancer|March 24, 2010
The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrenceDavid G Hicks, Bagi R Janarthanan, Ramya Vardarajan, et al.
Pageof 22

Showing results (191-200 of 219) with videos related to

Sort By:
Pageof 22
The Journal of Biological Chemistry|September 5, 2001
RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancerB S Finlin, C L Gau, G A Murphy, et al.
Plos One|May 1, 2020
Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational researchJose Rodrigo Espinosa Fernandez, Bedrich L Eckhardt, Jangsoon Lee, et al.
Clinical Radiology|April 12, 2017
Strengths and limitations of coronary angiography with turbo high-pitch third-generation dual-source CTM M Ochs, F Andre, G Korosoglou, et al.
JCO Precision Oncology|February 17, 2022
Clinical Activity of Pembrolizumab in a Patient With Metastatic Triple-Negative Breast Cancer Without Tumor Programmed Death-Ligand 1 Expression: A Case Report and Correlative Biomarker AnalysisSajjad Bhatti, Jaimie Heldstab, Carolyn Lehn, et al.
Clinical Lung Cancer|December 23, 2022
27-gene Immuno-Oncology (IO) Score is Associated With Efficacy of Checkpoint Immunotherapy in Advanced NSCLC: A Retrospective BC Cancer StudyDavid L Saltman, Matthew G Varga, Tyler J Nielsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancerBrian Z Ring, Robert S Seitz, Rod Beck, et al.
Breast Cancer Research : BCR|July 10, 2010
Mammostrat as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapyJohn M S Bartlett, Jeremy Thomas, Douglas T Ross, et al.
Astrobiology|December 6, 2023
The Atacama Rover Astrobiology Drilling Studies (ARADS) ProjectB Glass, D Bergman, V Parro, et al.
Human Reproduction (Oxford, England)|July 6, 2016
Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery ratesH Van der Ven, J Liebenthron, M Beckmann, et al.
BMC Cancer|March 24, 2010
The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrenceDavid G Hicks, Bagi R Janarthanan, Ramya Vardarajan, et al.
Pageof 22